Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38

1.

Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure.

McMurray JJ, Krum H, Abraham WT, Dickstein K, Køber LV, Desai AS, Solomon SD, Greenlaw N, Ali MA, Chiang Y, Shao Q, Tarnesby G, Massie BM; ATMOSPHERE Committees Investigators.

N Engl J Med. 2016 Apr 21;374(16):1521-32. doi: 10.1056/NEJMoa1514859. Epub 2016 Apr 4.

2.

Use of a basal-plus insulin regimen in persons with type 2 diabetes stratified by age and body mass index: A pooled analysis of four clinical trials.

Lankisch MR, Del Prato S, Dain MP, Mullins P, Owens DR.

Prim Care Diabetes. 2016 Feb;10(1):51-9. doi: 10.1016/j.pcd.2015.05.003. Epub 2015 Jul 4.

3.

The systemic immune network in recent onset type 1 diabetes: central role of interleukin-1 receptor antagonist (DIATOR Trial).

Kolb H, Lückemeyer K, Heise T, Herder C, Schloot NC, Koenig W, Heinemann L, Martin S; DIATOR Study Group.

PLoS One. 2013 Aug 26;8(8):e72440. doi: 10.1371/journal.pone.0072440. eCollection 2013.

4.

Improved preservation of residual beta cell function by atorvastatin in patients with recent onset type 1 diabetes and high CRP levels (DIATOR trial).

Strom A, Kolb H, Martin S, Herder C, Simon MC, Koenig W, Heise T, Heinemann L, Roden M, Schloot NC; DIATOR Study Group.

PLoS One. 2012;7(3):e33108. doi: 10.1371/journal.pone.0033108. Epub 2012 Mar 20.

5.

Assessment of aortic valve area combining echocardiography and magnetic resonance imaging.

Nickl W, Füth R, Smettan J, Köhler T, Lankisch M, Kramer F, Krahn T, Barroso MC, Klein RM, Dinh W.

Arq Bras Cardiol. 2012 Mar;98(3):234-42. Epub 2012 Feb 29. English, Portuguese, Spanish.

6.

High sensitive troponin T and heart fatty acid binding protein: novel biomarker in heart failure with normal ejection fraction? A cross-sectional study.

Dinh W, Nickl W, Füth R, Lankisch M, Hess G, Zdunek D, Scheffold T, Barroso MC, Tiroch K, Ziegler D, Seyfarth M.

BMC Cardiovasc Disord. 2011 Jul 5;11:41. doi: 10.1186/1471-2261-11-41.

7.

A progressive increase in cardiovascular risk assessed by coronary angiography in non-diabetic patients at sub-diabetic glucose levels.

Schinner S, Füth R, Kempf K, Martin S, Willenberg HS, Schott M, Dinh W, Scherbaum WA, Lankisch M.

Cardiovasc Diabetol. 2011 Jun 24;10:56. doi: 10.1186/1475-2840-10-56.

8.

Metabolic syndrome with or without diabetes contributes to left ventricular diastolic dysfunction.

Dinh W, Lankisch M, Nickl W, Gies M, Scheyer D, Kramer F, Scheffold T, Krahns T, Sause A, Füth R.

Acta Cardiol. 2011 Apr;66(2):167-74.

PMID:
21591574
9.

Growth-differentiation factor-15: a novel biomarker in patients with diastolic dysfunction?

Dinh W, Füth R, Lankisch M, Hess G, Zdunek D, Scheffold T, Kramer F, Klein RM, Barroso MC, Nickl W.

Arq Bras Cardiol. 2011 Jul;97(1):65-75. Epub 2011 May 13. English, Portuguese, Spanish.

10.

Relation of global longitudinal strain to left ventricular geometry in aortic valve stenosis.

Dinh W, Nickl W, Smettan J, Koehler T, Bansemir L, Lankisch M, Scheffold T, Barroso MC, Gülker JE, Füth R.

Cardiol J. 2011;18(2):151-6.

11.

Residual beta cell function in newly diagnosed type 1 diabetes after treatment with atorvastatin: the Randomized DIATOR Trial.

Martin S, Herder C, Schloot NC, Koenig W, Heise T, Heinemann L, Kolb H; DIATOR Study Group.

PLoS One. 2011 Mar 11;6(3):e17554. doi: 10.1371/journal.pone.0017554.

12.

Cardiovascular autonomic neuropathy contributes to left ventricular diastolic dysfunction in subjects with Type 2 diabetes and impaired glucose tolerance undergoing coronary angiography.

Dinh W, Füth R, Lankisch M, Bansemir L, Nickl W, Scheffold T, Bufe A, Krahn T, Ziegler D.

Diabet Med. 2011 Mar;28(3):311-8. doi: 10.1111/j.1464-5491.2010.03221.x.

PMID:
21204960
13.

Limiting esophageal temperature in radiofrequency ablation of left atrial tachyarrhythmias results in low incidence of thermal esophageal lesions.

Sause A, Tutdibi O, Pomsel K, Dinh W, Füth R, Lankisch M, Glosemeyer-Allhoff T, Janssen J, Müller M.

BMC Cardiovasc Disord. 2010 Oct 26;10:52. doi: 10.1186/1471-2261-10-52.

14.

Insulin resistance and glycemic abnormalities are associated with deterioration of left ventricular diastolic function: a cross-sectional study.

Dinh W, Lankisch M, Nickl W, Scheyer D, Scheffold T, Kramer F, Krahn T, Klein RM, Barroso MC, Füth R.

Cardiovasc Diabetol. 2010 Oct 15;9:63. doi: 10.1186/1475-2840-9-63.

15.

Reduced global longitudinal strain in association to increased left ventricular mass in patients with aortic valve stenosis and normal ejection fraction: a hybrid study combining echocardiography and magnetic resonance imaging.

Dinh W, Nickl W, Smettan J, Kramer F, Krahn T, Scheffold T, Barroso MC, Brinkmann H, Koehler T, Lankisch M, Füth R.

Cardiovasc Ultrasound. 2010 Jul 26;8:29. doi: 10.1186/1476-7120-8-29.

16.

Screening for overt diabetes by oral glucose tolerance test: stratification by fasting blood glucose and patients' age improve practicability of guidelines in cardiological routine.

Kempf K, Füth R, Dinh W, Bansemir L, Köhler T, Bufe A, Scheffold T, Standl E, Martin S, Lankisch M.

Int J Cardiol. 2011 Jul 15;150(2):201-5. doi: 10.1016/j.ijcard.2010.04.010. Epub 2010 Jun 12.

PMID:
20542339
17.

Gender-based differences in long-term outcome after ST-elevation myocardial infarction in patients treated with percutaneous coronary intervention.

Bufe A, Wolfertz J, Dinh W, Bansemir L, Koehler T, Haltern G, Guelker H, Füth R, Scheffold T, Lankisch M.

J Womens Health (Larchmt). 2010 Mar;19(3):471-5. doi: 10.1089/jwh.2009.1371.

PMID:
20136522
18.

Soluble P-selectin and matrix metalloproteinase 2 levels are elevated in patients with diastolic dysfunction independent of glucose metabolism disorder or coronary artery disease.

Füth R, Dinh W, Nickl W, Bansemir L, Barroso MC, Bufe A, Sause A, Scheffold T, Krahn T, Ellinghaus P, Lankisch M.

Exp Clin Cardiol. 2009 Fall;14(3):e76-9.

19.

Elevated plasma levels of TNF-alpha and interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders.

Dinh W, Füth R, Nickl W, Krahn T, Ellinghaus P, Scheffold T, Bansemir L, Bufe A, Barroso MC, Lankisch M.

Cardiovasc Diabetol. 2009 Nov 12;8:58. doi: 10.1186/1475-2840-8-58.

20.

Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention.

Kullmann S, Binner P, Rackebrandt K, Huge A, Haltern G, Lankisch M, Füth R, von Hodenberg E, Bestehorn HP, Scheffold T.

BMC Cardiovasc Disord. 2009 Oct 8;9:48. doi: 10.1186/1471-2261-9-48.

Supplemental Content

Loading ...
Support Center